Scalper1 News
Big pharma Merck’s stock jumped 5% Tuesday as the company’s first-quarter earnings beat estimates, bolstered by good news on its diabetes franchise. At the same time, big biotech and IBD 50 stock United Therapeutics fell 5.2% as its quarter missed views. Merck (MRK) reported earnings of 85 cents a share, down 3% from the year-earlier quarter but 10 cents better than analyst views. Sales shrank 8% to $9.43 billion but beat consensus by nearly $400 Scalper1 News
Scalper1 News